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Purpose: Carotid endarterectomy (CEA) has been shown to significantly reduce the risk of 
stroke cansed by carotid artery stenosis. Limiting the costs of CEA without increasing the 
risks will improve the cost-effectiveness of this procedure. 
Methods: Results were prospectively collected from 63 consecutive CEAs performed in 60 
patients who were entered into a clinical pathway for CEA that included avoidance of 
cerebral arteriography, preferential use of regional anesthesia, selective use of the inten- 
sive care unit (ICU), and early hospital discharge. The mortality rate, complications, 
hospital costs, and net income in these patients were then compared with results from 45 
CEAs performed in 42 consecutive patients immediately before beginning the CEA 
pathway. Age, comorbid risk factors, incidence of symptoms, and degree of carotidartery 
stenosis were similar in both patient groups. 
Results: The rates of mortality and complicadons associated with CEA were low (mortal- 
ity rate, 0%; stroke, 0.9%; transient ischemic attack, 2.8%) and did not vary between the 
two groups. Irnplementafion of the CEA pathway resulted in significant (p < 0.001) 
reductions in the use of arteriography (74% to 13%), general anesthesia (100% to 24%), 
ICU use i98% to 30%), and mean hospital length of stay (5.8 days to 2.0 days). These 
changes resulted in a 41% reduction in mean total hospital cost ($9652 to $5699) and a 
124% increase in mean net hospital income ($1804 to $4039) per CEA (p < 0.01). For 
the 39 patients (62%) who achieved all elements of the CEA pathway, the mean hospital 
length of stay was 1.3 days, the mean hospital cost was $4175, and the mean hospital 
income was $4327. 
Conclusion: Costs associated with CEA can be reduced substantially without increased 
risk. This makes CEA an extremely cost-effective treatment of carotid disease against 
which new therapeutic approaches must be measured. (J Vasc Surg 1997;26:456-64.) 
Carotid endarterectomy (CEA) is currently the 
most frequently performed peripheral vascular oper- 
auon. Although the value of CEA has been ques- 
tioned in the past, multiple recent rials have shown 
the benefit of CEA in reducing the risk ofstroke as a 
result of high-grade caroud artery stenosis in both 
symptomatic 1,2 and asymptomatic 3,4 patients. The 
findings of these studies will likely greatly expand the 
number ofCEAs performed and thereby significantly 
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increase the number ofpatients who can derive ben- 
eilt from CEA. The challenge that now faces vascular 
surgeons involves minimizing the costs associated 
with CEA in the current era of limited economic 
resources while avoiding adverse operative outcomes 
in an aged population with frequent medical comor- 
bidities. 
In the last 10 years, numerous revisions of  con- 
ventional diagnostic and therapeutic algorithms for 
patients who rcquire CEA have been implement- 
ed. s-16 Reports that detail these new approaches de- 
scribe changes in the preoperative assessment of  ca- 
rotid artery stenosis, the influence of anesthetic 
techniques during CEA, the need for intensive care 
unit monitoring after CEA, and a reduction in the 
length ofhospitalization. Patient safety has not been 
compromised by any of these changes, and cost saw 
ings as a result of  these changes have been implied. 
However, detailed hospital cost and reimbursement 
data is lacking in the majority of  these studies. In 
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addition, the authors of most of these studies have 
not used all of these diagnostic and therapeutic mod- 
ifications in attempting to streamline care and there- 
fore have not fully evaluated the potential optimal 
management of CEA patients in terms of safety and 
COSt. 
In 1994 we developed and implemented a clinical 
pathway for CEA that included reliance on duplex 
ultrasound as the primary method ofcharacterization 
of carotid artery stenosis, preferential use of regional 
anesthesia, selective use of postoperative intensive 
care, and attempted early hospital discharge. The 
frequency of adverse operative vents, hospital costs, 
and net hospital income were collected prospectively 
in patients treated in this manner. This report com- 
pares results from consecutive patients who entered 
the CEA pathway and a consecutive group of pa- 
tients who underwent CEA by the same surgeons in 
the same institution immediately before initiation of 
the CEA pathway. 
METHODS 
CEA pathway patients. During the 22-month 
interval from October i994 to July 1996, all patients 
who underwent elective CEA at Shands Hospital at 
the University of Florida were entered into a CEA 
clinical pathway and prospectively studied. Only pa- 
tients who underwent unilateral CEA as the primary 
procedure were included in the study. Combined 
procedures that involved coronary, subclavian, or 
vertebral artery revascularization a d urgent opera- 
tions were excluded. Bilateral CEAs were performed 
in a staged fashion during separate hospitalizations. 
Operative candidates included symptomatic patients 
(hemispheric transient ischemic attacks, amaurosis 
fugax, mild stroke) with >-70% stenosis of the ipsilat- 
eral internal carotid artery and asymptomatic patients 
with >-80% internal carotid artery stenosis. Assess- 
ment of carotid artery stenosis and development of 
an operative plan was performed using duplex ultra- 
sound scanning alone if possible. Contrast cerebral 
arteriography was indicated only for inadequate im- 
aging of the carotid bifurcation using duplex ultra- 
sound, possible internal carotid artery occlusion, re- 
current stenosis after previous CEA, and suspected 
diffuse or proximal carotid occlusive disease. Preop- 
erative evaluation included history and physical ex- 
amination, complete blood count, chemistry panel, 
coagulation parameters, urine analysis, and electro- 
cardiogram. Further cardiac or pulmonary evaluation 
was not performed unless recent symptoms ug- 
gested exacerbation rsignificant progression ofpre- 
existing disease (e.g., unstable angina, congestive 
heart failure, or severe chronic obstructive pulmo- 
nary disease). After informed consent was obtained 
at the outpatient preoperative visit, the pauent re- 
ceived a verbal and written overview of the CEA 
pathway and the planned perioperative care. 
After same-day admission, patients had indwell- 
ing radial artery catheters placed and intravenous 
antibiotics administered in the preoperative holding 
area. Regional (cervical block) anesthesia was used 
preferentially during CEA, and general anesthesia 
was reserved for patient's who were nervous, restless, 
or anxious, those with l~own high carotid bifurca- 
tions by preoperative arteriography, those who re- 
quired redo carotid procedures, and those who re- 
fused regional anesthesia. Continuous assessment of
the patient's level of consciousness and neurologic 
status was done by frequent questioning and assess- 
ment of the patient's ability to squeeze toy squeakers 
in both hands when regional anesthesia was used. 
Intraoperative electroencephalograph (EEG) moni- 
toring was used rarely according to the preference of 
the attending anesthesiologist. CEA was performed 
using standard surgical techniques, and temporary 
carotid shunts were placed only for adverse neuro- 
logic changes. Patch angioplasty of the carotid clo- 
sure was liberally applied, with decreasing use of 
saphenous vein and increasing use of the Dacron 
Hemashield patch (Meadox Medical Inc, Oakland, 
N.J.) during the seiles. 
Patients were closely monitored in the postanes- 
thetic care unit (PACU) for 2 to 6 hours after sur- 
gery. No laboratory tests were obtained after surgery 
unless warranted by severe preexisting medical con- 
ditions or adverse intraoperative events. If the pa- 
tient's neurologic, ardiac, and pulmonary status had 
not been compromised, significant cervical hema- 
toma did not evolve, and blood pressure was stable 
or easily controlled without continuous infusions of 
vasoactive agents, direct ransfer to the surgical floor 
was done at the end of this time period. Direct 
admission to the surgical intensive care unit (SICU) 
from the operating room was done for significant 
intraoperative h modynamic instability or intraoper- 
ative complications (e.g., myocardial ischemia, isch- 
emic neurologic event). Transfer from the PACU to 
the SICU was done when blood pressure instability 
was not easily controlled using oral medications or 
when significant complications (e.g., cervical hema- 
toma requiring drainage) developed. After transfer to 
the surgical ward, neurologic hecks were performed 
every 2 hours for 8 hours and then every 4 hours, and 
vital signs were monitored every 4 hours by the ward 
personnel. Patients were discharged home on the 
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first postoperative day if no neurologic, cardiac, pul- 
monary, or wound problem developed, blood pres- 
sure was weil controlled, signifieant headache was 
not present, and they were able to eat, void, and 
ambulate. Clinic visits were scheduled for 1 week and 
1 to 3 months after surgery. 
Pre-CEA pathway patients. Before instituting 
the CEA pathway, patients were treated in a standard 
manner, as weil. Duplex ultrasound scanning was 
used to initially determine the degree of carotid dis- 
ease present in patients who were being considered 
for CEA, and this assessment was confirmed by con- 
trast cerebral arteriography unless that study was 
contraindicated (contrast allergy, no vascular access, 
patient refusal). The clinical management plan was 
then based on results of both of these studies. Com- 
parison of results of these two imaging studies was 
also used to confirm the accnracy of duplex ultra- 
sound carotid imaging in the Vascular Diagnostic 
Laboratory. General anesthesia was used routinely, 
shunting was performed in all patients, and EEG 
monitoring was used whenever possible. Patients 
were monitored in the SICU for at least 24 hours 
after CEA and were then observcd on the surgical 
ward for approximately 4 days before discharge. Af- 
ter hospital discharge, follow-up was the same as for 
patients entered into the CEA pathway. 
Data coUection and statistical analysis. Data 
describing patient demographics, neurologic symp- 
toms, comorbid medical conditions, prcoperative ca- 
rotid assessment, anesthetic route, operative techni- 
cal maneuvers, postoperative management, length of 
hospitalization, complications and deaths within 30 
days of operation, and hospital costs and income 
were eollected. Hospital costs and reimbursement 
associated with each patient who underwent CEA 
were obtained from the Office of Clinical Resource 
Management, Shands Hospital at the University of 
Florida. Direct variable and total hospital costs and 
hospital reimbursement were provided for each pa- 
tient, allowing calculation of ner hospital income 
(hospital reimbursement - otal hospital costs). Di- 
rect variable costs represent the savings to the insti- 
tution for each instance that a specific resource is not 
used, whereas total cost reflects all costs that are 
incurred on each resource use as well as fixed costs 
associated with the site of use, such as the operating 
room and its personnel. Fixed costs are equally dis- 
tributed over all patients who use a specific hospital 
resource. Hospital patient charges were not used, as 
these represent the highest level mix of local and 
distant institutional costs shiffed among sites that 
generate revenues and losses. 
Data collected for patients in the CEA pathway 
werc compared with data from a similar consecutive 
patient cohort of patients who underwent CEA in 
the 33 months bcfore implementation f the path- 
way (Ianuary 1992 to October 1994). Statistical 
analysis between CEA pathway and prepathway 
groups and within groups was performed with un- 
paired t tests for continuous variables that have an 
assumed normal distribution. For nonparamen'ic dis- 
tributions, X2 analysis was used for nominal measures 
and Mann-Whimey tank sum tests for ordinal vari- 
ables. Statistical significance was defined as a p value 
less than 0.05. Data are presented as mean + stan- 
dard deviation where appropriate. 
RESULTS 
Sixty-three CEA proeedures were performed in 
60 consecutive patients using the CEA pathway. For- 
ty-five CEAs were performed in 42 consecutive pa- 
tients in the 33 months preceding implementation f 
the CEA pathway. Three patients in each group un- 
derwent staged, bilateral CEAs dnring separate hos- 
pitalizations. Fifty-one CEA procedures (47%) were 
performed in 51 patients for neurologic symptoms, 
including recent ransient ischemic attacks or amau- 
rosis fugax in 40 patients and recent reversible isch- 
emic nenrologic deficits or documented strokes in 
11. Fifty-seven CEA procedures (53%) were per- 
formed in 51 patients (six bilateral staged CEAs) for 
asymptomatic, high-grade (>80%) carotid artery ste- 
nosis. The mean age of all patients who underwent 
CEA was 69 years (range, 50 to 90 years). Preopera- 
tive hypertension was present in 63 patients, signifi- 
cant coronary artery disease in 50, and congestive 
heart failure in 13. Eighty-three patients were cur- 
rent or prior tobacco users, and 10 had chronic 
obstructive pulmonary disease. A previous CEA pro- 
cedure had been performed in 20 patients (five ipsi- 
lateral and 15 contralateral). Age distribution, 
presence of comorbid risk factors, incidence of neu- 
rologic symptoms and previous CEA, and degree of 
carotid artery stenosis did not dißEr statistically be- 
tween the CEA pathway and prepathway patient 
groups (p > 0.05; Table I). 
No perioperative deaths occurred. The overall 
adverse neurologic event rate was 3.7%, with one 
probable strokc (0.9%) and three transient ischemic 
attacks (2.8%). Temporary cranial nerve injuries oc- 
curred in six cases (5.6%), cervical hematomas that 
required operative vacuation i  three cases (2.8%), 
and cervical wound infections in four cases (3.7%). 
All cranial nerve deficits were transient and were 
manifested by hoarseness in three cases of presumed 
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Table I. Demographic data and neurologic 
symptoms between CEA groups 
CEA pathway Prepathway 
(n=60) (n=42) 
Mean age (yr) 68.9 69.3 
Hypertension 63% 60% 
Tobacco use 79% 84% 
Coronary artcry disease 50% 48% 
Congcstive heart failure 12% 14% 
Chronic obstructive pulmonary 12% 7% 
disease 
Overall symptomatic 46% 49% 
Previous troke 13% 7% 
TIA/amaurosis fugax 33% 42% 
Previous CEA 16% 22% 
Mean % stenosis by duplex 82% 79% 
vagal injury, marginal mandibular nerve palsies in 
two cases, and difficult deglutition in one case of 
hypoglossal injury. One cranial nerve injury occnrred 
during CEA in one of the five patients who was 
undergoing a redo ipsilateral procedure. Other com- 
plications included three saphenous vein harvest 
wound infections, two cases of perioperative cardiac 
ischemia, onc myocardial infarction (which occurred 
I week after discharge home), and single instances of 
postoperative syncope, urinary retention, and cor- 
neal abrasion. M1 cervical and vein harvest site wound 
infections were superficial but required a course of 
antibiotics, and several required open packing. Only 
the CEA patient who had a myocardial infarction 
after discharge home required readmission within 30 
days for complications relatcd to CEA. The rates of 
adverse neurologic events, cranial nerve injury, 
wound complications, and other complications were 
similar between pathway and prepathway patient 
groups (p > 0.05; Table II). 
Duplex ultrasound scanning providcd adequate 
preopcrative assessment of the degree of carotid ar- 
tery stenosis in 52 of 60 CEA pathway patients 
(87%). Cerebral contrast arteriograms were obtained 
for the remaining eight pathway patients for inade- 
quate imaging at the carotid bifurcation in four pa- 
tients, possible internal artery occlusion in two, and 
recurrent stenosis and previous proximal common ca- 
rotid artery reconstruction in one eäch. In contrast, 31 
of 42 patients (74%) who underwent CEA before insti- 
nation of the CEA pathway tmderwent preoperative 
cerebral contrast arteriography (p< 0.001). 
CEA was performed with the patient under re- 
gional anesthesia in 48 pathway cases, whereas 15 
procedures werc performed with the patient under 
general anesthesia, including two procedures in 
which regional ancsthesia was convcrted to general 
Table II. Adverse outcomes after CEA 
CEA pathway Prepathway 
(n = 63) (n = 45) 
Stroke 1 (1.6%) 0 (0%) 
Transient ischemic attack 2 (3.2%) 1 (2.2%) 
Cranial nerve injury 4 (6.4%) 2 (4.4%) 
Cervical hematoma 3 (4.8%) 0 (0%) 
Wound infecuon 2 (3.2%) 2 (4.4%) 
Other complications 6 (9.6%) 3 (6.6%) 
Table III. Opcrative management of
CEA groups 
CEA pathway Prepathway 
(n = 63) (n = 45) 
Regional anesthesia use 76% 0%* 
Carotid shunting 29% 100%* 
EEG monitoring 21% 82%* 
Patch closure 65% 89%* 
*Significant difference at p < 0.01. 
anesthesia during the procedure because of an inad- 
cquate block (Tablc III). The indications for general 
anesthesia n the rcmaining 13 patients were patient 
preference in 11, a high lesion at the level of the 
second cervical vertebra in one, and a redo carotid 
procedure in one. The average times of operating 
room use for CEA pathway procedures performed 
with the patient under regional and general anesthe- 
sia were identical (4.2 hours). Eighteen pathway pa- 
tients rcquired temporary carotid shunting, and 13 
had EEG monitoring. However, shunting was neces- 
sary for altercd neurologic status in only three of 48 
procedurcs performcd with the patient under re- 
gional anesthetic. Shunts were placed during the 
rcmaining 15 proccdures because of surgcon prefer- 
cnce in patients who undergo CEA under general 
anesthesia. Similarly, EEG monitoring was only per- 
formed in the 13 pathway patients in whom general 
ancsthesia was planned. All patients who underwent 
CEA bcfore the CEA pathway undcrwent the opera- 
tion with general anesthesia and temporary carotid 
shunting, and 37 had EEG monitoring. Patch clo- 
sure of the carotid artcry was pcrformed less fre- 
quendy in pathway cases than in prepathway cases. 
SICU monitoring/management was necessary 
after 19 CEAs (30%) performcd after the instination 
of the CEA pathway (Table IV). PACU monitoring 
(for an average of 5.2 hours) was done after the 
remaining 44 cases. Thirteen of 15 patients who 
underwent CEA under general anesthesia were ad- 
mitted to the SICU, compared with six of 48 patients 
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Table IV. Indications for ICU admission in 
CEA pathway patients 
No. of 
patients 
Surgeon preference 4 
Preoperative comorbid conditions 4 
Cardiac ischemia 3 
Dysrhythmias 3 
Cervical hematoma 2 
Hypertension requiring intravenous infusions 1 
Hoarseness/alrway compromise 1 
Altered mental status 1 
Total 19 
who underwent CEA with regional anesthesia (p < 
0.001). Admission to the SICU was directly from the 
operating room in lö cases, and problems developed 
in the PACU that required subsequent SICU moni- 
toring in three cases (two neck hematomas, one of 
which required operative drainage, and one episode 
of cardiac ischemia). No CEA pathway patients re- 
quired admission to the SICU after discharge from 
the PACU to the surgical floor. SICU monitoring 
was done in 43 of 44 prepathway cases (98%; p < 
0.001). The length of observation i the SICU was 
for 1 day or less in 18 of 19 pathway cases (95%) and 
37 of 43 (86%) prepathway cases. 
The mean hospital length ofstay was 1.98 _+ 2.39 
days in the CEA pathway group compared with 5.78 _ 
3.65 days in the prepathway group (p < 0.001). Ad- 
mission before CEA for preoperative evaluation, cere- 
bral arteriography, or both (range, 1 to 6 days; mean, 
1.7 days) and longer postoperative observation both 
contributed to a longer length ofstay in the prepathway 
patients. Fifty-two percent of pathway patients were 
discharged home on the first postoperative day, and 
83% were discharged by the second postoperative day. 
In contrast, only three of the patients treated before 
beginning the CEA pathway were discharged home by 
the second postoperative day. Postoperative complica- 
tions were the primary determinant oflength ofstay in 
CEA pathway patients, in whom complications oc- 
curred before discharge in only 7.7% ofpatients dis- 
charged by the second postoperarive day compared 
with 73% of those discharged after the second post- 
operative day. The type ofanesthesia used in pathway 
patients appeared to strongly influence the incidence 
of complications, with the complication rate in path- 
way patients who underwent CEA with regional an- 
esthesia being 12.5% (six adverse vents in 48 pa- 
tients) compared with 53.3% (eight events in 15 
patients) in those who underwent CEA under gen- 
eral anesthesia (p < 0.01). 
Table V. Hospital costs and reimbursement 





Direct variable cost ($) 
Total hospital cost ($) 
Net reimbursement ($) 
Net hospital income ($) 
2415 ± 2616 
5699 ± 5673 
9739 ± 4151 
4039 ± 3946 
4147 ± 1311" 
9652 ± 3153" 
11,456 ± 4072* 
1804 ± 4143" 
*Significant difference atp < 0.05. 
Both mean direct variable costs and mean total 
costs were higher for prepathway CEA patients com- 
pared with CEA pathway patients (Table V). Net 
hospital reimbursement was also greater for the 
prepathway group compared with the CEA pathway 
group, and this could not be attributed to varying 
contributions from different primary payers because 
Medicare was the primary payor for the majority of 
patients in this study. However, the higher reim- 
bursement for prepathway patients was not sufficient 
to offset higher direct variable and total hospital 
costs, so that mean riet hospital income (difference 
between net reimbursement and total cost) was 
greater for CEA pathway patients than for pre- 
pathway patients (p < 0.01). Cost reductions were 
achieved primarily by use of duplex ultrasound imag- 
ing (average total cost, $164) rather than cerebral 
contrast arteriography (average total cost, $2099) for 
preoperative carotid imaging, by use of the PACU 
(average total cost, $483 for 5.2 hours) rather than 
the SICU (average total cost, $1035 for 1 to 24 
hours) for initial postoperaüve monitoring, and by 
early discharge from the hospital (the average total 
cost for 1 postoperative day ofcare in uncomplicated 
pathway patients was $181 versus $2079 for the 
average total costs for 5 postoperative days ofcare in 
uncomplicated prepathway pafients). The large dis- 
parity between average total costs for postoperative 
days ofpathway and prepathway patients is a result of 
the high costs of ICU care extending into the first 
postoperafive day and the additional days ofobserva- 
tion on the surgical ward in prepathway pafients and 
the minimal costs occurring on the first postoperative 
day when more than half of the pathway patients 
went home. Operating room total costs were not 
different between patients who underwent CEA with 
either regional or general anesthesia. However, suc- 
cessful regional anesthesia n pathway patients elimi- 
nated the need for EEG monitoring, resulting in an 
average additional savings of $701 in total costs. 
Total hospital cost was lowest (mean, $4175) and 
net hospital income was highest (mean, $4327) for 
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patients who achieved all of the goals of the pathway 
(avoidance of contrast arteriography, use of regional 
anesthesia, direct transfer to the surgical ward from 
the PACU, and early hospital discharge). Further- 
more, compared with prepathway values, the total 
hospital cost was also lower (mean, $8185) and the 
net hospital income was also higher (mean, $3582) 
for patients entered into the pathway who only par- 
tially achieved these goals. 
DISCUSSION 
This study demonstrates that the introduction of 
a critical pathway for patients who undergo CEA for 
both symptomatic and asymptomatic carotid diseasc 
can lead to significant cost reductions without affect- 
ing the risk of the proccdure. Similar to the approach 
advocated by Collier, sthis pathway consisted ofpre- 
operative carotid evaluation using only duplex ultra- 
sound, hospital admission the day of CEA, use of 
regional anesthesia, postoperative monitoring in the 
recovcry room, and discharge homc within 24 hours 
whenever possible. Dawson et al. 6 have reported that 
a technically adequate carotid uplex ultrasound pro- 
vides sutficient information for the development of
an accurate preoperative plan in 98% of CEA cases, 
and Gollcdge et al.7 and Shifrin et al.8 have shown 
that additional information from cerebral contrast 
arteriograms modifies the care of patients who un- 
dergo CEA at most 1% of the time. In addition, the 
majority of changes in care based on information 
obtaincd from the cerebral artcriogram could be 
made on the basis of operative findings, as weil. 
Corson et al.9 have reported that CEA performed 
with the patient under regional anesthesia s associ- 
ated with less postoperative hypertension than CEA 
performed with the patient under general ancsthesia, 
and Allen et al.l° found fewer cardiopulmonary com- 
plications after CEA using regional anesthesia com- 
parcd with general anesthesia, similar to the rcsults 
reported here. O'Brien et al., n McGrath et al.,12 and 
Morasch et al.t3 have shown that only 18%, 18%, and 
2i%, respectively, ofpatients who undergo CEA re- 
quire ICU care, and that subsequent problems that 
necessitate ICU care rarely develop in patients who 
arc neurologically and hemodynamically stable in the 
recovery room for 2 to 4 hours. Finally, Collier 5 and 
Hoyle et al. 14 have shown that early hospital dis- 
charge after CEA is safe and that few patients will 
have problems that requirc readmission. Acceptable 
perioperative morbidity and mortality rates have 
been maintained in all of these reports when these 
modifications of conventional diagnostic and thera- 
peutic algorithms for CEA have becn used. The 
study presented here demonstrates that low morbid- 
ity and mortality rates (combined stroke and death 
rate of 1.6%) can be achieved when these modifica- 
tions are combined. 
Because the morbidity and mortality rates associ- 
ated with conventional treatment algorithms for pa- 
tients who undergo CEA are low, a primary motiva- 
tion in investigating these modifications ofCEA has 
been reducing the costs associated with the proce- 
dure. Hoyle et al.14 reported a 29% cost reduction for 
CEA with the introduction of a case management 
protocol for cerebral revascularizätion that consisted 
of CEA performed with the patient under general 
anesthesia, observation i  the recovery room for 3 
hours, intensive monitoring on the surgical ward by 
specially trained nurses, and discharge on the second 
postoperative day. Similarly, Hirko et al. is demon- 
strated a 32% decrease in hospital charges between 
1990 and 1994 as cerebral contrast arteriography 
use, SICU use, and hospital length ofstay associated 
with CEA decreased. I@aiss et al. 16 reported amore 
substantial 47% reduction of hospital charges associ- 
ated with CEA with the use ofa streamlined protocol 
that eliminated routine cerebral arteriography, used 
regional anesthesia, nd limited SICU monitoring to 
high risk patients. However, only 18 patients who 
underwent CEA using this streamlined protocol 
were studie& 
The CEA pathway used in the current study is 
similar to the streamlined protocol used by Kraiss et 
al., 16 and the 41% reduction in total hospital costs 
and 41.8% reduction in direct variable costs are sim- 
ilar to the 47% reduction i  hospital charges reported 
by those authors. These findings in a larger group of 
patients further demonstrate he success of this ag- 
gressive approach to reducing the costs associated 
with CEA. In addition, the results presented here 
may more accurately reflect he impact of these mod- 
ifications in patient care on costs associated with 
CEA as direct variable costs and total hospital eosts 
rather than hospital charges (which are subject o 
more variability) were used. Limiting use of routine 
preoperative cerebral eontrast arteriography, SICU 
monitoring, and postoperative observation on the 
surgieal ward each resulted in direct eost reductions. 
In contrast, use of regional anesthesia was associated 
with the same direct variable and total operating 
room costs as general anesthesia. However, use of 
regional anesthesia resulted in direet cost savings 
from decreased use of EEG monitoring and indirect 
savings from decreased ICU monitoring and risk of 
postoperative complications compared with general 
anesthesia. The incidence ofcomplications oeeurring 
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in pathway patients who underwent CEA under gen- 
eral anesthesia was high compared with our prepath- 
way patients and the series of others that describe 
CEA performed with the patient under a general 
anesthetic but could not be accounted for by differ- 
ences in comorbid factors or neurologic symptoms. 
Any conclusions drawn from this observafion must 
be tempered by the small numbers ofpatients in this 
group and the absence of a randomized protocol for 
comparing the types of anesthesia used in our study. 
Regardless, the significant increase in net hospital 
profit confirms the pathway's value in improving the 
cost effectiveness of CEA. 
Publication of the results from large multicenter 
trials of treatment of symptomatic 1,2 and asymptom- 
atic 3,4 patients with significant carotid atherosclerosis 
has led to increased use of CEA in patients with 
carotid artery disease. 17 The estimated cost of this 
increased use in the stare ofFlorida may be as high as 
$50 million annually. 18 Therefore, with the continu- 
ing efforts to limit the economic resources devoted to 
medical care, it is imperative for CEA to be made as 
cost-effective as possible so that this highly effective 
procedure for stroke prevention will remain widely 
available. In addition, carotid balloon angioplasty 
and stenting are currently being investigated as an 
alternative to CEA in the treatment of significant 
carotid atherosclerosis, and one of the proposed po- 
tential benefits of carotid balloon angioplasty is a 
reduction in the cost of therapy) 9 Initial use of this 
procedure in our institution has been associated with 
direct variable costs that range from $2400 to $5200 
and total costs that range from $5800 to $11,400. 
Although these costs will likely diminish as carotid 
angioplasty and steht placement procedures are re- 
fined, at least at present it does not appear that 
carotid balloon angioplasty and stenting will be sig- 
nificantly less costly than CEA performed in a cost- 
effective manner. Comparison of balloon angioplasty 
with stenting and standard CEA for the treatment of 
significant carotid disease can therefore be based on 
the clinical effectiveness and risks of each procedure, 
as their costs appear to be similar. 
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DISCUSSION 
Dr. Will iam H. Edwards, Sr. (Nashville, Tenn.). I 
want to congratulate Dr. Back on bis presentation and the 
Florida group for bringing this very timely topic to us. By 
creating a pathway for patients with cerebral occlusive 
disease, they have initiated a study that has supported the 
fact the quality ofcare is not impaired by cost resource use. 
They now have undertaken the ditficult ask of standardiz- 
ing surgical care in one specific area, carotid endarterec- 
tomy. We began a similar process at St. Thomas in 1991 in 
which we looked only at the length of stay in the intensive 
care unit and hospital length ofstay. The report his morn- 
ing, ofcourse, extends this to the type ofanesthetic used as 
well as preoperative angiography. This study confirms our 
findings, which showed a decreased length of stay in both 
the intensive care unit and hospital and ä mean sävings to 
the hospital of about $2000 per patient. Intuitively, the 
site of convalescence after CEA probably should have no 
effect on the morbidity or mortality rate. This was the case 
in their 60 patients on the pathway when compared with 
the compärable group of 42 patients who underwent oper- 
ation before the institution of the pathway. By the same 
token, shortened hospital ength of stay should have no 
effect on the morbidity or mortality rate. All of us who 
perform CEAs lmow full weil that if the patient is neuro- 
logically intact with no hematoma 8 to 24 hours after the 
operation that there is probably not going to be a serious 
stroke or a hemorrhage. Whether or not we agree, it is time 
to step back and evaluate the use of resources in patients 
who need CEA and, for that marter, any other vascular or 
other surgical procednre. 
None of us question the efficacy of CEA. We now need 
to critically evaluate our use ofresources. Dr. Back's group 
has included angiography in their evaluation. I think this is 
very important. Angiography, ofconrse, has been the stan- 
dard against which noninvasive studies have been judged 
for many years, and this was pointed out this morning. 
When a diagnostic procedure, however, carries a risk of 
stroke, as well as the complications of the contrast me- 
dium, it is time to seriously reassess its role. The early 
reports, which relied on duplex scans alone, were begun to 
reduce these risks, and probably the first report was by Bill 
Blackshear some 14 years ago. Bill was a member of this 
organization. In the study by Dr. Back and his colleagues, 
they reduced the use ofangiography from 74% to 13%. The 
need for resource use gives us added incentives to reevalu- 
ate some of these preconceived and previous concepts. 
Much has been said and written about pathways, best 
practice patterns, and practice guidelines. To many, it is 
perceived as an intrusion on the surgeon and the manage- 
ment of their patients. This notwithstanding, it is an etfi- 
cient, effective technique in the management of particular 
surgical procedures such as CEA but can also be extended 
to all vascular procedures 0r all other surgical procedures. 
When we initiated case management, we believed thät it 
was essential to involve all the personal who were going to 
be involved in patient care. We clearly explained to the 
patient hat they would be able to leave the hospital much 
sooner than they had in the pastor that was the usual case 
and that they would probably not spend any time in an 
intensive care unit but would return to their room to be 
with their families overnight. They liked this and were very 
accepting of the concept. 
I would ask Dr. Back, did you find the same thing? 
Because in the manuscfipt you detailed the fact that you 
talked to the patients to explain to them exactly what was 
going on. You reported a wonnd infection rate, however, 
oftwo cases in each series. It seemed alittle bit high. In the 
manuscript, you do not describe the antibiotic regimen. I 
wonder whether you might teil us what it was. Before the 
pathways, you were patching 89% and shunting 100% of 
patients. In the pathway group, the use of patches de- 
creased to 65%, and most patches were Dacron as he has 
stated in his manuscript. Before that time, they were using 
saphenous vein. The use of shunts also decreased. Was 
there any relationship between this decreased use ofshunts 
and the change in the percentage of patching? Dr. Back 
points out in his manuscript that the interventionalists are 
eagerly awaiting the opportunity to capture the care of the 
patient, meaning aCEA. It is essential that we all work very 
diligently to continue to lower the cost of CEA without 
impairing quality. 
Dr. Mart in IL Back. Thank you, Dr. Edwards, for 
your insightful overview and questions. The first question 
pertains to preoperative patient education. All patients, 
when seen in the vascular surgery clinic, were given a verbal 
and a written overview of the planned pathway and their 
perioperative care, and any questions were initially an- 
swered at that time. The second question pertained to 
antibiotic regimen. All patients received a single dose of a 
first-generation cephalosporin before their operation. No 
postoperative antibiotics were used, and that was indepen- 
dent of the use of patch closure. The final question re- 
garded the use of shunts and patch closures. Patch closure, 
although widely used at our institntion, was performed less 
ftequently after the implementation of the pathway be- 
canse of a change in preference of one of the attending 
surgeons. The decreased use of shunts during the pathway 
occurred because most procedures were performed with 
the patient under regional anesthesia, where neurologic 
status could be continuously monitored. The trends in 
shunt use and path closure were not directly related. 
Dr. John A. Mannick (Boston, Mass.). I am a litfle 
concerned about leaving the audience with the impression 
that general anesthesia s automatically followed by a stay 
in an ICU after carotid endarterectomy. I don't really 
think, in spite of your data, that is likely to be the case at 
most hospitals. Certainly, in our own unit, we havc used 
general anesthesia n 100% of CEA procedures for years, 
and I cannot remember the last time we sent one of those 
patients to the ICU after the operation. 
JOUKNAL OF VASCULAR SURGERY 
464 Back et al. September 1997 
Dr. Back. Only a small number of patients in the 
pathway received a general anesthetic, so any conclusions 
drawn from their analysis must be tempered. In this group, 
however, we observed more frequent use of the ICU after 
the operation mainly as a result of a higher rate of compli- 
cations than for patients receiving regional anesthesia. 
Dr. John S. Kirkland (Rome, Ga.). I enjoyed your 
paper. We have recently looked at some of the same issues 
you have raised. In 1993 we were having an angiographic 
use rate of about 70%. The incidence of ICU stay was 
about 50%, and the mean length ofstay was around 7 days. 
In 1996, using an approach similar to yours, our rate of 
angiographic use is less than 30%, and the ICU is used in 
less than 10% ofcases. We do use 100% general anesthesia. 
The mean length of stay in the most recently reported 
period through 1996 was 1.8 days, and the hospital cost 
was $4284. This is in approximately 300 patients. It is 
certainly possible to achieve avery limited use of the ICU 
and still use general anesthesia. I am likewise a bit con- 
cerned about he number of complications in your general 
anesthetic patients. Do you think that is because you se- 
lected the sicker patients for general anesthesia, or is there 
some other factor? 
Dr. Back. In the review ofour data, we were unable to 
find a higher incidence of medical comorbidities or neuro- 
logic symptoms in the pathway patients who received gen- 
eral anesthesia to help explain the higher complication rate 
in this group. 
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